Pomdoctor Ltd ADR Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Reporting Calendar
| Event | Expected Date |
|---|---|
| First Half 2026 Unaudited Financial Results | 3 Dec 2026 |
Monitoring Framework
Key Performance Indicators
Cumulative Contracted Doctors Annually212.8K
Transacting Patients Annually699.3K
Annual Prescriptions Issued Annually3.1M
Average Revenue Per Paying Patient (RMB) Annually766.0
Watch Items
- Nasdaq Minimum Bid Price ComplianceTrigger: Closing bid price below $1.00 for 30 consecutive business daysAction: Implement the 1-for-18 reverse ADS split (ADS ratio change) effective June 22, 2026, to artificially boost the trading price above the $1.00 threshold.
- Going Concern and Liquidity RiskTrigger: Net current liabilities of RMB 113.2 million and cash reserves of only RMB 9.6 million as of December 31, 2025Action: Secure additional financing, optimize operating cash burn (which was RMB 148.5 million in FY2025), and accelerate monetization of the digital healthcare platform.
- Securities Class Action LitigationTrigger: Active lawsuits alleging a pump-and-dump scheme and failure to disclose stock promotion activitiesAction: Engage legal counsel to defend the company and monitor potential financial liabilities or settlement requirements.
Research as of 19 Jun 2026